Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes

Niels Grarup, Ida Moltke, Mette K Andersen, Maria Dalby, Kristoffer Vitting-Seerup, Timo Kern, Yuvaraj Mahendran, Emil Jørsboe, Christina V L Larsen, Inger K Dahl-Petersen, Arthur Gilly, Daniel Suveges, George Dedoussis, Eleftheria Zeggini, Oluf Pedersen, Robin Andersson, Peter Bjerregaard, Marit E Jørgensen, Anders Albrechtsen, Torben Hansen

Research output: Contribution to journalJournal articleResearchpeer-review

97 Downloads (Pure)

Abstract

We have identified a variant in ADCY3 (encoding adenylate cyclase 3) associated with markedly increased risk of obesity and type 2 diabetes in the Greenlandic population. The variant disrupts a splice acceptor site, and carriers have decreased ADCY3 RNA expression. Additionally, we observe an enrichment of rare ADCY3 loss-of-function variants among individuals with type 2 diabetes in trans-ancestry cohorts. These findings provide new information on disease etiology relevant for future treatment strategies.

Original languageEnglish
JournalNature Genetics
Volume50
Issue number2
Pages (from-to)172–174
ISSN1061-4036
DOIs
Publication statusPublished - Feb 2018

Keywords

  • Journal Article

Fingerprint

Dive into the research topics of 'Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes'. Together they form a unique fingerprint.

Cite this